Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII expression in liver disease.

Martine J Hollestelle1, Hendrika G M Geertzen, Irene H Straatsburg

  • 1Department of Plasma Proteins, Sanquin Research at CLB, Amsterdam, The Netherlands.

Thrombosis and Haemostasis
|February 13, 2004
PubMed
Summary

Elevated factor VIII (FVIII) in liver cirrhosis stems from increased von Willebrand factor (VWF) synthesis and reduced low-density lipoprotein receptor-related protein (LRP) expression, not higher FVIII production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical handling of hemolytic, icteric and lipemic samples for coagulation testing in European laboratories. A collaborative survey from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).

Clinical chemistry and laboratory medicine·2025
Same author

Short-term biological variation of coagulation and fibrinolytic measurands.

Clinical chemistry and laboratory medicine·2025
Same author

D-dimer-An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World.

Seminars in thrombosis and hemostasis·2024
Same author

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers-for the External Quality Assurance in Thrombosis and Haemostasis Group.

Seminars in thrombosis and hemostasis·2024
Same author

Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands.

Clinical chemistry and laboratory medicine·2023
Same author

The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.

European journal of cancer (Oxford, England : 1990)·2023

Area of Science:

  • Hepatology
  • Hematology
  • Molecular Biology

Background:

  • Liver disease often presents with elevated factor VIII (FVIII) and reduced synthesis of other proteins.
  • The precise mechanism behind increased FVIII in liver disease remains unclear.

Purpose of the Study:

  • To investigate the mechanism of elevated plasma factor VIII (FVIII) in liver cirrhosis.
  • To examine the expression of FVIII, von Willebrand factor (VWF), and low-density lipoprotein receptor-related protein (LRP) in liver disease patients.

Main Methods:

  • Analysis of FVIII, VWF, and LRP mRNA and protein levels in liver tissue samples from patients with cirrhosis, liver failure, and controls.
  • Immunohistochemical analysis of VWF protein distribution and LRP-producing cells.

Related Experiment Videos

Main Results:

  • Cirrhotic livers showed significantly lower hepatic FVIII and LRP mRNA but higher VWF mRNA compared to controls.
  • Increased VWF protein distribution and reduced LRP-producing cells were observed in cirrhotic tissue.
  • Plasma levels of FVIII and VWF were significantly elevated in patients with cirrhosis.

Conclusions:

  • Elevated plasma FVIII in liver cirrhosis is linked to increased hepatic VWF biosynthesis and decreased LRP expression.
  • The findings suggest that increased FVIII levels are not due to enhanced FVIII synthesis in the liver.